Advertisement

Topics

Impax Laboratories, Inc. (IPXL) Rating Reiterated by Cowen and Company

19:57 EST 11 Nov 2017 | Topix

's stock had its "hold" rating restated by equities research analysts at Cowen and Company in a report issued on Friday. They presently have a $16.00 price target on the specialty pharmaceutical company's stock.

Original Article: Impax Laboratories, Inc. (IPXL) Rating Reiterated by Cowen and Company

NEXT ARTICLE

More From BioPortfolio on "Impax Laboratories, Inc. (IPXL) Rating Reiterated by Cowen and Company"

Advertisement
Quick Search
Advertisement
Advertisement